Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Stephen R. Saklad"'
Publikováno v:
Mental Health Clinician, Vol 12, Iss 4, Pp 254-262 (2023)
Introduction: Olanzapine (OLZ) is a second generation antipsychotic that is approved for the treatment of schizophrenia, bipolar disorder type 1 as monotherapy (acute manic or mixed episodes, maintenance), or as an add-on to lithium or valproate (man
Externí odkaz:
https://doaj.org/article/338e1f1e2e444690aef4c7208fd0d9eb
Publikováno v:
Mental Health Clinician, Vol 12, Iss 5, Pp 320-326 (2022)
Antipsychotic (AP) medications are prescribed for various psychiatric diagnoses that require routine monitoring to ensure optimal use, effectiveness, adherence, and for potentially severe adverse effects. There is currently no comprehensive protocol
Externí odkaz:
https://doaj.org/article/529e7f0ac0de4e13b7b1d757dacd2d76
Autor:
Batool Haider, Amy K O'Sullivan, Leona Bessonova, Elizabeth Keane, Eric Achtyes, Philip D Harvey, John M Kane, Stephen R Saklad, Jeffrey P Trotter, Amy Claxton, Tiffany Polak, James McGrory, Wahidullah Noori, Asia Sikora Kessler, Aaron Yarlas, Dawn Velligan
Publikováno v:
Neuropsychiatric Disease and Treatment.
Batool Haider,1 Amy K OâSullivan,1 Leona Bessonova,1 Elizabeth Keane,1 Eric Achtyes,2 Philip D Harvey,3 John M Kane,4 Stephen R Saklad,5 Jeffrey P Trotter,6 Amy Claxton,1 Tiffany Polak,1 James McGrory,1 Wahidullah Noori,1 Asia Sikora Kessler,7 A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e854f66c3f5ec101f1247c72a6bf32e
https://www.dovepress.com/changes-in-clinical-management-of-patients-with-schizophrenia-treated--peer-reviewed-fulltext-article-NDT
https://www.dovepress.com/changes-in-clinical-management-of-patients-with-schizophrenia-treated--peer-reviewed-fulltext-article-NDT
Autor:
Daniel, Dowd, Gabriela, Williams, Daniel, VanDorn, Stephen, Clarke, David S, Krause, Jeffrey, Botbyl, Stephen R, Saklad
Publikováno v:
The American journal of managed care. 28(11)
Drug-drug interactions (DDIs) are among the most common causes of adverse drug reactions and are further complicated by genetic variants of drug-metabolizing enzymes. The aim of this study is to quantify and describe potential DDIs, drug-gene interac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b90942d5508d96343fe5c961c635f998
https://pubmed.ncbi.nlm.nih.gov/36374614
https://pubmed.ncbi.nlm.nih.gov/36374614
Autor:
Daniel Dowd, Gabriela Williams, David Krause, Stephen Clarke, Eric Crumbaugh, Jeffrey Botbyl, Stephen R. Saklad
Publikováno v:
CNS Spectrums. 27:236-237
IntroductionAdverse drug reactions (ADRs) are associated with increased morbidity, mortality, and resource utilization. Drug interactions (DDIs) are among the most common causes of ADRs, and estimates have cited that up to 22% of patients take intera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c09b8174328398ee39c06c9d2017adc
https://doi.org/10.1017/s1092852922000372
https://doi.org/10.1017/s1092852922000372
Autor:
Leona Bessonova, Elizabeth Keane, Eric Achtyes, Philip D. Harvey, John M. Kane, Stephen R. Saklad, Jeffrey Trotter, Amy Claxton, Tiffany Hatfield, James McGrory, Wahidullah Noori, Amy K. O’Sullivan, Joshua E. Biber, Asia Sikora Kessler, Aaron Yarlas, Dawn I. Velligan
Publikováno v:
CNS Spectrums. 27:230-230
BackgroundThe COVID-19 pandemic substantially impacted care of patients with schizophrenia treated with long-acting injectable antipsychotics (LAIs). This study examined how clinics adapted operations to maintain a standard of care for these patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::217fab1bfe95fdeacf079288e0913d8a
https://doi.org/10.1017/s1092852922000256
https://doi.org/10.1017/s1092852922000256
Autor:
Srihari Gopal, Christoph U. Correll, Maju Mathews, Stephen R. Saklad, Wayne Hamm, Raja Venkatasubramanian, Jennifer Kern Sliwa, Edward Kim
Publikováno v:
CNS Drugs
The availability of long-acting injectable (LAI) antipsychotics for the treatment of schizophrenia provides clinicians with options that deliver continuous drug exposure and may improve adherence compared with daily oral antipsychotics. However, all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e4166f5a3be06a5e0229e6e119e888f
https://pubmed.ncbi.nlm.nih.gov/33507525
https://pubmed.ncbi.nlm.nih.gov/33507525
Autor:
Stephen R. Saklad, Leslie Citrome
Publikováno v:
The Journal of clinical psychiatry. 81(2)
The use of second-generation antipsychotics has not eliminated tardive dyskinesia (TD), and the prevalence of the disorder is higher than commonly realized. The involuntary movements of TD can decrease patients' quality of life, cause embarrassment,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3aa18bdf94b7b4a9d0936da40e1e55a8
https://pubmed.ncbi.nlm.nih.gov/32078259
https://pubmed.ncbi.nlm.nih.gov/32078259
Autor:
Stephen R. Saklad
Publikováno v:
The Journal of clinical psychiatry. 81(1)
Tardive dyskinesia (TD) is an involuntary movement disorder induced by dopamine-receptor blocking agents (DRBAs), including antipsychotics. Because the introduction of second-generation antipsychotics has reduced but not eliminated the risk for TD as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c07cef53266a17ecf9ab60c88fbb07e6
https://pubmed.ncbi.nlm.nih.gov/31944066
https://pubmed.ncbi.nlm.nih.gov/31944066
Publikováno v:
Drugs. 77:403-426
Gabapentinoid (pregabalin and gabapentin) abuse is increasingly being reported.To assess the extent of gabapentinoid abuse, characteristics of typical abusers, patterns of abuse, and potential harms in order to bring this trend to providers' attentio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa56e7a46d840c67b7a836e5ed9566e9
https://doi.org/10.1007/s40265-017-0700-x
https://doi.org/10.1007/s40265-017-0700-x